Back
United Therapeutics Stock Predictions
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
49
UTHR
United Therapeutics
Last Price:
$362.68
Seasonality Move:
6.42%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.United Therapeutics Stock Forecast
-
Over the next 52 weeks, United Therapeutics has on average historically risen by 21.9% based on the past 25 years of stock performance.
-
United Therapeutics has risen higher in 15 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is United Therapeutics Stock Undervalued?The current United Therapeutics [UTHR] share price is $359.58. The Score for UTHR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
UTHR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will United Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, United Therapeutics has on average historically risen by 21.9% based on the past 25 years of stock performance.
United Therapeutics Stock Rating
Sell
49
United Therapeutics (UTHR)
is a Sell
Is United Therapeutics overpriced?
-
United Therapeutics has risen higher in 15 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
United Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
unither.com
52-Week Data
52-Week High:
417.82
52-Week Low:
208.62
Prediction Charts
Market Cap:
16.1B
Price in USD:
359.58
Volume:
925.6K
Beta:
0.53
Technical Analysis
SMA50:
370.25
SMA100:
357.41
SMA200:
315.65
52-Wk Change:
59.45%
Stock Predictions
-
Is United Therapeutics stock public?Yes, United Therapeutics is a publicly traded company.
-
What is the United Therapeutics stock quote today?The United Therapeutics stock price is 359.58 USD today.
-
How to buy United Therapeutics stock online?You can buy United Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-3 | 369.84 | 368.79 | 374.86 | 364.76 |
| Dec-4 | 368.98 | 374.40 | 374.92 | 367.94 |
| Dec-5 | 372.17 | 374.37 | 377.00 | 369.07 |
| Dec-6 | 373.58 | 369.67 | 378.27 | 367.13 |
| Dec-9 | 370.69 | 367.00 | 371.93 | 362.44 |
| Dec-10 | 368.02 | 362.24 | 368.02 | 358.55 |
| Dec-11 | 363.51 | 362.16 | 366.07 | 360.59 |
| Dec-12 | 362.00 | 361.61 | 364.91 | 360.46 |
| Dec-13 | 362.40 | 361.81 | 362.94 | 358.82 |
| Dec-16 | 362.35 | 372.83 | 373.17 | 362.00 |
| Dec-17 | 372.19 | 379.69 | 381.50 | 372.19 |
| Dec-18 | 379.59 | 357.43 | 383.00 | 356.06 |
| Dec-19 | 357.55 | 360.16 | 364.61 | 350.60 |
| Dec-20 | 359.50 | 359.58 | 363.90 | 357.99 |
United Therapeutics Earnings
United Therapeutics Earnings Report: Per Share United Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
United Therapeutics Forecast Revenue Growth
United Therapeutics Stock Analysis: Historical quarterly revenues per share for United Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $1.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.70 per share, and an increase next year of $2.67 per share.
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.